MS4A1 and myeloid sarcoma: CD20+ T cells show an activated proinflammatory phenotype and have been increasingly implicated in the pathogenesis of autoimmune diseases, particularly MS and its animal model, experimental autoimmune encephalomyelitis (EAE).